Find, compare & contact
Alvimopan API Manufacturers & Suppliers

Looking for Alvimopan API 156053-89-3?

Description:

Here you will find a list of producers, manufacturers and distributors of Alvimopan. You can filter on certificates such as GMP, FDA, CEP, Written Confirmation and more. Send inquiries for free and get in direct contact with the supplier of your choice.

API | Excipient name:

Alvimopan 

Synonyms:

Alvimopan anhydrous , Anhydrous alvimopan  

Cas Number:

156053-89-3 

DrugBank number:

DB06274 

Unique Ingredient Identifier:

Q153V49P3Z

Alvimopan is a type of Motility inhibitors

Motility inhibitors are a subcategory of pharmaceutical active pharmaceutical ingredients (APIs) that are used to regulate and control the movement of the gastrointestinal tract. These inhibitors play a crucial role in treating conditions such as irritable bowel syndrome (IBS), gastroesophageal reflux disease (GERD), and other gastrointestinal disorders.

Motility inhibitors work by blocking the action of certain neurotransmitters and receptors in the gastrointestinal tract, thereby reducing the frequency and intensity of contractions in the smooth muscles. This leads to a decrease in the speed of food passage through the digestive system, providing relief from symptoms like abdominal pain, bloating, and diarrhea.

One commonly used motility inhibitor is metoclopramide, which acts by inhibiting dopamine receptors in the gastrointestinal tract. It enhances the contractions of the stomach and small intestine while relaxing the muscles of the pyloric sphincter, thus improving gastric emptying and reducing reflux.

Another important motility inhibitor is loperamide, which works by slowing down the muscular contractions of the intestines. It is commonly used to treat diarrhea by increasing the time it takes for stool to move through the digestive system.

Motility inhibitors are available in various forms, including tablets, capsules, and oral suspensions. They are generally well-tolerated, but like any medication, they can have side effects such as drowsiness, dizziness, and constipation.

In summary, motility inhibitors are an essential subcategory of pharmaceutical APIs used to manage gastrointestinal disorders by regulating the movement of the digestive tract. They provide relief from symptoms and improve overall digestive function, enhancing the quality of life for individuals suffering from these conditions.

Alvimopan (Motility inhibitors), classified under Gastrointestinal Agents

Gastrointestinal Agents belong to the pharmaceutical API category that focuses on treating disorders and ailments related to the digestive system. These agents play a crucial role in addressing various gastrointestinal conditions, such as acid reflux, ulcers, irritable bowel syndrome (IBS), and inflammatory bowel disease (IBD).

One of the key types of gastrointestinal agents is proton pump inhibitors (PPIs), which work by reducing the production of stomach acid. PPIs help in treating conditions like gastroesophageal reflux disease (GERD) and peptic ulcers. Another essential class of agents is antacids, which neutralize excessive stomach acid, providing relief from heartburn and indigestion.

Gastrointestinal agents also include antispasmodics that alleviate abdominal cramps and spasms associated with conditions like IBS. These drugs work by relaxing the smooth muscles of the digestive tract. Additionally, there are drugs categorized as laxatives that aid in relieving constipation by promoting bowel movements.

Moreover, certain gastrointestinal agents act as antiemetics, effectively reducing nausea and vomiting. These drugs are particularly useful for patients undergoing chemotherapy or experiencing motion sickness.

Pharmaceutical companies develop and manufacture a wide range of gastrointestinal agents in various forms, including tablets, capsules, suspensions, and injections. These agents are typically formulated using active pharmaceutical ingredients (APIs) and other excipients to ensure their efficacy and safety.

In conclusion, gastrointestinal agents form a vital category of pharmaceutical APIs, providing relief from digestive disorders and improving overall gastrointestinal health. The availability of diverse agents catering to different conditions ensures that patients can receive targeted treatment for their specific gastrointestinal needs.

• Apino Pharma Co., Ltd. from China, product country of origin China
• Teva API from Israel, product country of origin Unknown
• MSN Life Sciences from India, product country of origin India

Let the supplier know whether you are looking for a product with a specific monograph such as EP (Ph. Eur.), USP, JP, BP or another quality. Or, whether you are looking for hydrochloride (HCl), anhydricum, base, micronisatum or a specific purity.

You can use the filters to find high-quality suppliers. For example, you can select GMP, FDA or ISO certified suppliers. Visit our FAQ page or use the chat box in the corner to get more information about Pharmaoffer.